Martinotti E - Search Results

1

Structural modifications of benzanilide derivatives, effective potassium channel openers. X.

Calderone V, Coi A, Fiamingo FL, Giorgi I, Leonardi M, Livi O, Martelli A, Martinotti E. Calderone V, et al. Among authors: martinotti e. Eur J Med Chem. 2006 Dec;41(12):1421-9. doi: 10.1016/j.ejmech.2006.07.016. Epub 2006 Oct 6. Eur J Med Chem. 2006. PMID: 17030483

2

Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.

Cecchetti V, Calderone V, Tabarrini O, Sabatini S, Filipponi E, Testai L, Spogli R, Martinotti E, Fravolini A. Cecchetti V, et al. Among authors: martinotti e. J Med Chem. 2003 Aug 14;46(17):3670-9. doi: 10.1021/jm030791q. J Med Chem. 2003. PMID: 12904071

3

1,5-Diarylsubstituted 1,2,3-triazoles as potassium channel activators. VI.

Biagi G, Calderone V, Giorgi I, Livi O, Martinotti E, Martelli A, Nardi A. Biagi G, et al. Among authors: martinotti e. Farmaco. 2004 May;59(5):397-404. doi: 10.1016/j.farmac.2004.01.012. Farmaco. 2004. PMID: 15120319

4

Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V.

Biagi G, Giorgi I, Livi O, Nardi A, Calderone V, Martelli A, Martinotti E, LeRoy Salerni O. Biagi G, et al. Among authors: martinotti e. Eur J Med Chem. 2004 Jun;39(6):491-8. doi: 10.1016/j.ejmech.2004.02.006. Eur J Med Chem. 2004. PMID: 15183907

5

NO-sartans: a new class of pharmacodynamic hybrids as cardiovascular drugs.

Breschi MC, Calderone V, Digiacomo M, Martelli A, Martinotti E, Minutolo F, Rapposelli S, Balsamo A. Breschi MC, et al. Among authors: martinotti e. J Med Chem. 2004 Nov 4;47(23):5597-600. doi: 10.1021/jm049681p. J Med Chem. 2004. PMID: 15509155

6

1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII.

Calderone V, Giorgi I, Livi O, Martinotti E, Martelli A, Nardi A. Calderone V, et al. Among authors: martinotti e. Farmaco. 2005 May;60(5):367-75. doi: 10.1016/j.farmac.2005.03.004. Farmaco. 2005. PMID: 15910810 Review.

7

Benzoyl and/or benzyl substituted 1,2,3-triazoles as potassium channel activators. VIII.

Calderone V, Giorgi I, Livi O, Martinotti E, Mantuano E, Martelli A, Nardi A. Calderone V, et al. Among authors: martinotti e. Eur J Med Chem. 2005 Jun;40(6):521-8. doi: 10.1016/j.ejmech.2005.01.010. Epub 2005 Mar 3. Eur J Med Chem. 2005. PMID: 15922836

8

New NO-releasing pharmacodynamic hybrids of losartan and its active metabolite: design, synthesis, and biopharmacological properties.

Breschi MC, Calderone V, Digiacomo M, Macchia M, Martelli A, Martinotti E, Minutolo F, Rapposelli S, Rossello A, Testai L, Balsamo A. Breschi MC, et al. Among authors: martinotti e. J Med Chem. 2006 Apr 20;49(8):2628-39. doi: 10.1021/jm0600186. J Med Chem. 2006. PMID: 16610806

9

Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX.

Calderone V, Fiamingo FL, Giorgi I, Leonardi M, Livi O, Martelli A, Martinotti E. Calderone V, et al. Among authors: martinotti e. Eur J Med Chem. 2006 Jun;41(6):761-7. doi: 10.1016/j.ejmech.2006.03.009. Epub 2006 Apr 19. Eur J Med Chem. 2006. PMID: 16626840

10

Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels.

Calderone V, Martelli A, Testai L, Martinotti E, Breschi MC. Calderone V, et al. Among authors: martinotti e. Naunyn Schmiedebergs Arch Pharmacol. 2007 Mar;375(1):73-80. doi: 10.1007/s00210-006-0129-3. Epub 2007 Jan 4. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17203288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page